跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BP-8
首页
药物
BP-8
BP-8
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Gene knockout method based on base editing and its application
US 11248225 B2
申请人: SUZHOU MAXIMUM BIO TECH CO LTD
优先权: 2017
CN
US
WO
4 件公开
Nucleic acid useful for triggering tumor cell lethality
US 2007197458 A1
申请人: DUTREIX MARIE
优先权: 2003
EP
US
3 件公开
Antibiotics, tripropeptins and process for producing the same
US 7271147 B2
申请人: ZAIDAN HOJIN BISEIBUTSU
优先权: 2000
US
2 件公开
Cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
US 8754040 B2
申请人: SEKIMIZU KAZUHISA
优先权: 2010
US
2 件公开
Human testicular development specificity protein-8 gene coding protein
CN 1316435 A
申请人: UNIV NANJING MEDICAL
优先权: 2001
CN
Murine DNase X, pharmaceuticals containing thereof and non-human mammal with modified DNase X-gene
EP 1249495 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2001
EP
3 novel humanized tumor cell reproduction and tumor transfer suppressor genes
CN 1386858 A
申请人: INST OF RADIOMEDICINE ACADEMY
优先权: 2001
CN
ARL-2 for fertility control
EP 1304378 A1
申请人: SCHERING AG
优先权: 2001
EP
Slit1 and MEGF4 isoforms and uses thereof
EP 1364965 A1
申请人: METAGEN PHARMACEUTICALS GMBH
优先权: 2002
EP
New gene SNX21 of human SNX family
CN 1425677 A
申请人: UNIV HUNAN NORMAL
优先权: 2002
CN
第 1 / 4 页
上一页
下一页
药物
反馈